Oxytocin evokes a pulsatile PGE2 release from ileum mucosa and is required for repair of intestinal epithelium after injury

Sci Rep. 2015 Jul 10:5:11731. doi: 10.1038/srep11731.

Abstract

We measured the short-circuit current (Isc) in rat ileum mucosa to identify the effect of oxytocin (OT) on mucosal secretion in small intestine. We identified a COX-2-derived pulsatile PGE2 release triggered by OT in rat ileum mucosa. OT receptors (OTR) are expressed in intestine crypt epithelial cells. Notably, OT evoked a dynamic change of [Ca(2+)]i in ileum crypts, which was responsible for this pulsatile release of PGE2. OT ameliorated 5-FU-, radiation- or DSS- induced injury in vivo, including the improvement of weight loss, reduced villus height and impaired survival of crypt transit-amplifying cells as well as crypt. Moreover, these protective effects of OT against intestinal injury were eliminated by coadministration of a selective inhibitor of PGE2, AH6809. Our findings strongly suggest that OT, a novel and important regulator of intestine mucosa barrier, is required for repair of intestinal epithelium after injury. Considering that OT is an FDA-approved drug, this work reveals a potential novel and safe way to combat or prevent chemo-radiotherapy induced intestine injury or to treat IBD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / toxicity
  • Calcium / metabolism
  • Cyclooxygenase 2 / chemistry
  • Cyclooxygenase 2 / metabolism
  • Dextran Sulfate / toxicity
  • Dinoprostone / analysis
  • Dinoprostone / antagonists & inhibitors
  • Dinoprostone / metabolism*
  • Disease Models, Animal
  • Enzyme-Linked Immunosorbent Assay
  • Evoked Potentials / drug effects
  • Fluorouracil / toxicity
  • Ileum / drug effects
  • Ileum / injuries
  • Ileum / metabolism
  • Immunohistochemistry
  • Indomethacin / pharmacology
  • Intestinal Diseases / chemically induced
  • Intestinal Diseases / drug therapy
  • Intestinal Mucosa / drug effects*
  • Intestinal Mucosa / injuries
  • Intestinal Mucosa / metabolism
  • Ions / chemistry
  • Ions / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Microscopy, Fluorescence
  • Neoplasms / drug therapy
  • Neoplasms / radiotherapy
  • Oxytocin / pharmacology*
  • Oxytocin / therapeutic use
  • Rats
  • Rats, Wistar
  • Receptors, Oxytocin / metabolism
  • Wound Healing / drug effects
  • Xanthones / pharmacology

Substances

  • Antineoplastic Agents
  • Ions
  • Receptors, Oxytocin
  • Xanthones
  • 6-isopropoxy-9-oxoxanthene-2-carboxylic acid
  • Oxytocin
  • Dextran Sulfate
  • Cyclooxygenase 2
  • Dinoprostone
  • Calcium
  • Fluorouracil
  • Indomethacin